Fig. 5From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)Changes in bacteriuria status of patients throughout the clincical trial. Number of patients with significant, non significant and unknown bacteriuria on Day 0, Day 7 and Day 37 respectively and the changes in bacteriuria status throughout the clinical trial (full analysis set, N = 125). In case of “unknown bacteriuria” or “no growth” no bacterial analysis was possibleBack to article page